Forte Biosciences (FBRX) EPS (Basic) Growth (3y) (2019 - 2026)
Forte Biosciences (FBRX) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
85.94% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
41.58% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Forte Biosciences |
70.77 Mn |
12.55 Mn |
- |
-57.07% |
| Date | Value |
|---|
| Mar 31, 2026 |
-57.07% |
| Dec 31, 2025 |
-82.13% |
| Sep 30, 2025 |
-76.52% |
| Jun 30, 2025 |
-65.97% |
| Mar 31, 2025 |
-100.49% |
| Dec 31, 2024 |
157.85% |
| Sep 30, 2024 |
-103.34% |
| Jun 30, 2024 |
-150.76% |
| Mar 31, 2024 |
-123.70% |
| Dec 31, 2023 |
-42.82% |
| Sep 30, 2023 |
-144.41% |
| Jun 30, 2023 |
64.67% |
| Mar 31, 2023 |
30.90% |
| Dec 31, 2022 |
18.90% |
| Sep 30, 2022 |
91.83% |
| Jun 30, 2022 |
91.12% |
| Mar 31, 2022 |
38.75% |
| Dec 31, 2021 |
39.75% |
| Sep 30, 2021 |
-200.00% |
| Jun 30, 2021 |
19.03% |
